Articles with "invasive bladder" as a keyword



Smoking Behaviors and Prognosis in Patients With Non–Muscle-Invasive Bladder Cancer in the Be-Well Study

Sign Up to like & get
recommendations!
Published in 2022 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2022.44430

Abstract: Key Points Question Are tobacco smoking and marijuana use associated with recurrence risk in patients with non–muscle-invasive bladder cancer (NMIBC)? Findings In this cohort study of 1472 adults with NMIBC, two-thirds of whom were former… read more here.

Keywords: invasive bladder; recurrence risk; patients non; risk ... See more keywords

Tertiary Lymphoid Structures are Linked to Enhanced Antitumor Immunity and Better Prognosis in Muscle‐Invasive Bladder Cancer

Sign Up to like & get
recommendations!
Published in 2024 at "Advanced Science"

DOI: 10.1002/advs.202410998

Abstract: The prognosis for muscle‐invasive bladder cancer (MIBC) remains poor, and reliable prognostic markers have yet to be identified. Tertiary lymphoid structures (TLS) have been associated with favorable outcomes in certain cancers. However, the relationship between… read more here.

Keywords: tertiary lymphoid; prognosis muscle; lymphoid structures; muscle invasive ... See more keywords

Clinical evaluation of urine laminin‐γ2 monomer as a potent biomarker for non‐muscle invasive bladder cancer

Sign Up to like & get
recommendations!
Published in 2022 at "Cancer Medicine"

DOI: 10.1002/cam4.5087

Abstract: To evaluate whether urine laminin‐γ2 monomer (Ln‐γ2m) offers a useful biomarker for patients with non‐muscle‐invasive bladder cancer (NMIBC). read more here.

Keywords: invasive bladder; urine laminin; non muscle; laminin monomer ... See more keywords

Preoperative systemic inflammation response index is an independent prognostic marker for BCG immunotherapy in patients with non‐muscle‐invasive bladder cancer

Sign Up to like & get
recommendations!
Published in 2022 at "Cancer Medicine"

DOI: 10.1002/cam4.5284

Abstract: The Systemic Inflammatory Response Index (SIRI) is a novel prognostic biomarker based on peripheral blood counts of neutrophils, monocytes, and lymphocytes. Recent evidence suggests that it is associated with poor prognosis in various cancers. However,… read more here.

Keywords: invasive bladder; response index; bladder cancer; non muscle ... See more keywords

Comparative cost‐effectiveness of neoadjuvant chemotherapy regimens for muscle‐invasive bladder cancer: Results according to VESPER data

Sign Up to like & get
recommendations!
Published in 2022 at "Cancer"

DOI: 10.1002/cncr.34502

Abstract: The VESPER trial demonstrated improved progression‐free (PFS) and (preliminarily) overall survival (OS) with six cycles of neoadjuvant dose‐dense methotrexate, vinblastine, doxorubicin, and cisplatin (ddMVACx6) versus four cycles of gemcitabine and cisplatin (GCx4) before radical cystectomy… read more here.

Keywords: cancer; invasive bladder; bladder cancer; muscle invasive ... See more keywords

FDA approves durvalumab for perioperative immunotherapy for patients with muscle‐invasive bladder cancer

Sign Up to like & get
recommendations!
Published in 2025 at "Cancer"

DOI: 10.1002/cncr.35912

Abstract: This news section offers Cancer readers timely information on events, public policy analysis, topical issues, and personalities. In this issue, the FDA has approved the first perioperative immunotherapy (durvalumab) for patients with muscle‐invasive bladder cancer.… read more here.

Keywords: cancer; perioperative immunotherapy; muscle invasive; invasive bladder ... See more keywords

Poor clinical outcomes and immunoevasive contexture in interleukin‐9 abundant muscle‐invasive bladder cancer

Sign Up to like & get
recommendations!
Published in 2020 at "International Journal of Cancer"

DOI: 10.1002/ijc.33237

Abstract: Chemotherapy and immunotherapy yield survival benefits for muscle‐invasive bladder cancer (MIBC) patients, in which tumor microenvironment has been found to exert crucial roles through tipping the balance between antitumor immunity and immune evasion. Our study… read more here.

Keywords: cells infiltration; bladder cancer; invasive bladder; infiltration ... See more keywords

“Inchworm sign” in urinary bladder cancer

Sign Up to like & get
recommendations!
Published in 2018 at "Abdominal Radiology"

DOI: 10.1007/s00261-018-1614-0

Abstract: Local T-stage in bladder cancer depends on the depth of tumor invasion through the lamina propria (T1) and muscle layers (T2) of the bladder wall, the presence of penetration into the perivesical fat (T3), or… read more here.

Keywords: bladder cancer; invasive bladder; bladder; inchworm sign ... See more keywords

Biparametric magnetic resonance imaging assessment for detection of muscle-invasive bladder cancer: a systematic review and meta-analysis

Sign Up to like & get
recommendations!
Published in 2022 at "European Radiology"

DOI: 10.1007/s00330-022-08696-5

Abstract: To investigate if removing DCE from the Vesical Imaging Reporting and Data System (VI-RADS) influences the diagnostic accuracy of muscle-invasive bladder cancer (MIBC). We also explored using different reference standards on the MRI diagnostic performance.… read more here.

Keywords: reference; cutoff scores; muscle invasive; bladder cancer ... See more keywords

Muscle-invasive bladder cancer organ-preserving therapy: systematic review and meta-analysis

Sign Up to like & get
recommendations!
Published in 2018 at "World Journal of Urology"

DOI: 10.1007/s00345-018-2384-6

Abstract: PurposeTo determine the effectiveness and harms of bladder-preserving trimodal therapy (TMT) as a first-line treatment versus radical cystectomy (RC) plus radical pelvic lymphadenectomy in the treatment of muscle-invasive bladder cancer in terms of overall survival.MethodsWe… read more here.

Keywords: bladder cancer; invasive bladder; muscle invasive; cancer ... See more keywords

Forty years of cisplatin-based chemotherapy in muscle-invasive bladder cancer: are we understanding how, who and when?

Sign Up to like & get
recommendations!
Published in 2018 at "World Journal of Urology"

DOI: 10.1007/s00345-018-2544-8

Abstract: PurposeFor 40 years cisplatin-based chemotherapy has been administered to patients with muscle-invasive bladder cancer (MIBC). The best evidence of its efficacy is found in the context of neoadjuvant chemotherapy (NAC). However, the benefit to the… read more here.

Keywords: chemotherapy; invasive bladder; cisplatin based; muscle invasive ... See more keywords